Antinuclear antibodies as potential markers of lung cancer.
about
The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells.Antinuclear antibodies define a subgroup of paraneoplastic neuropathies: clinical and immunological data.Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancerProteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma.Immune-Signatures for Lung Cancer Diagnostics: Evaluation of Protein Microarray Data Normalization Strategies.Improved approach to identify cancer-associated autoantigens.Optimizing the diagnostic power with gastric emptying scintigraphy at multiple time pointsAutoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis.Development of a T7 Phage Display Library to Detect Sarcoidosis and Tuberculosis by a Panel of Novel Antigens.Tumor-associated antigen arrays for the serological diagnosis of cancer.Shared immunoproteome for ovarian cancer diagnostics and immunotherapy: potential theranostic approach to cancer.Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera.Serologic laboratory findings in malignancy.The clinical significance of anti-mitotic spindle apparatus antibody (MSA) and anti-centromere antibody (ACA) detected in patients with small cell lung cancer (SCLC).Hypertrophic pulmonary osteoarthropathy with positive antinuclear antibodies: case report.Spectra of antinuclear antibodies in patients with squamous cell carcinoma of the lung and of the head and neck.
P2860
Q31018962-4A9C7DAC-BCC9-4B84-9AAE-EEDB8F6A5A9CQ31019096-E68E8888-4D90-43EB-BA05-FC589B80D729Q31042618-2DA7E462-FAF9-4599-B403-9598F9D5A9A3Q31105265-5686C392-8E41-4082-B1DE-CB68A2A11099Q31126986-054C38E4-34EE-4BA0-91D4-7A0470DD82EAQ33215080-B0A11877-2492-4B79-B9E7-D632BD1CD144Q33917526-69A5B33D-26C5-4A22-813F-29E9948B5FDDQ35632045-0BD811E9-3343-453E-8DE1-438ABA5F79C7Q35666895-B871F4FE-E947-4BAF-98CE-2991A51E7C50Q36491988-741BCC9B-8499-4398-BB09-17E9866D339EQ36871710-0C32B9C3-8BA5-4875-B400-158CEC7961C0Q37119458-0CAF7334-6E8D-42F5-B303-3FB3378247DFQ37401677-2432F68C-C6B0-4421-ABAD-78933AE1BDD3Q37692214-8EF9613D-9074-4710-82DC-D2CA5467A0F5Q40044567-66C7F95A-7CEA-454F-80B7-D8C3E4F59284Q50977348-4072747B-9D5B-4871-846D-25D268E0A7B0
P2860
Antinuclear antibodies as potential markers of lung cancer.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Antinuclear antibodies as potential markers of lung cancer.
@en
type
label
Antinuclear antibodies as potential markers of lung cancer.
@en
prefLabel
Antinuclear antibodies as potential markers of lung cancer.
@en
P2093
P2860
P1476
Antinuclear antibodies as potential markers of lung cancer
@en
P2093
F Fernández-Madrid
J E Tomkiel
J L Granda
P J VandeVord
P M Simpson
R L Karvonen
P2860
P304
P407
P577
1999-06-01T00:00:00Z